Mollie H. Wright

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics

Mollie H. Wright, Anna Maria Calcagno, Crystal D. Salcido et al. · Breast Cancer Research · 2008 · 660 citations · Full text

Medicine, Cell Biology, Oncology +17

Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance

Smitha Antony, Keli Agama, Ze‐Hong Miao et al. · Cancer Research · 2007 · 127 citations · Full text

Medicine, Oncology, Pharmacology +14

HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair

Thuy T. Koll, Steven S. Feis, Mollie H. Wright et al. · Molecular Cancer Therapeutics · 2008 · 82 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1

Mollie H. Wright, Ana I. Robles, Jason I. Herschkowitz et al. · Molecular Cancer · 2008 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Schedule-Dependent Synergy between the Heat Shock Protein 90 Inhibitor 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin and Doxorubicin Restores Apoptosis to p53-Mutant Lymphoma Cell Lines

Ana I. Robles, Mollie H. Wright, Bheru Gandhi et al. · Clinical Cancer Research · 2006 · 38 citations

Medicine, Oncology, Pharmacology +16